Search Results

< Back to Issue 2 What’s the forecast for smallholder farmers of Arabica coffee? For millions of smallholder farmers residing in the rural highlands of East Timor and Ethiopia, Arabica coffee is a major source of income. Yet, weather patterns are threatening their future livelihoods. With global coffee yields predicted to dramatically reduce in coming decades, how will this touch Melbourne’s privileged cafe culture? by Hannah Savage 10 December 2021 Edited by Ashleigh Hallinan & Irene Yonsuh Lee Illustrated by Aisyah Mohammad Sulhanuddin The world loves its coffee. After crude oil, coffee is the most exported commodity in the world and global demands are projected to skyrocket alongside demographic growth (2). With a strong inclination by Australian citizens to participate in our bourgeois cafe culture, Australian demand can be expected to mimic this trend. However, as climate change continues to throw curveballs, pressures to satisfy these demands will be felt by all in the supply chain. There are many species of coffee beans, yet global consumption relies only on a narrow genetic selection. Coffea Arabica is the dominant coffee bean species in commercial production (approximately 70 percent), followed by Coffea Robusta (2). Agricultural research and breeding of these crops are not extensive, considering their high sensitivity to climate. If Arabica was a child, it would be the no-mash-touching-the-peas type. Though a laborious crop to farm, this fussy plant has low yield when too much shade deprives it of sunlight or too little shade shrinks soil moisture levels. It insists on altitudes 1000-2000m above sea level and 2000mm of rainfall per annum (2). Moreover, the optimal air temperature for Arabica is 18-21 degrees Celsius (3). With these environmental specifications, it is expected that half of the world’s optimal areas for growth of Arabica and Robusta are expected to be lost by 2050 due to climate change (13). After Hurricane Maria hurtled across Puerto Rico in 2017, 80 percent of coffee trees were destroyed and rural livelihoods were flattened overnight (4). Climate change does not pay sympathy towards poor and marginalized rural communities. Frequency and intensity of extreme weather is increasing in many developing nations. Changes in temperature, weather events and rainfall patterns are already challenging the ability of farmers to adapt. Rainfall distribution is becoming more erratic and unpredictable. This is a key concern to farmers as rain patterns correlate with timing of flowering and fruit production (2). Flowering is usually triggered by the first rains of the wet season, yet unpredictable rains during the year may cause flowering at undesirable times. Unsynchronized ripening requires additional harvesting cycles, costing farmers more money and labour. In addition, water scarcity and warmer air temperature also have profound impacts on harvests. Prolonged drought leads to misshapen or small beans with marks and imperfections (3). Low moisture and heat stress causes wilting, death of crops or acceleration of bean growth (3). At temperatures above 23 degrees, fruit ripens too fast for a rich, sweet coffee flavour to develop (2). What will thrive from these changing climatic conditions are pests, diseases and coffee rust fungus, which are becoming more prevalent in areas previously unfavourable for their survival (5). The insect Coffee berry borer has been a particular challenge to coffee producers globally, as it feeds on coffee beans and damages plantations. One to four generations of these critters are born each fruiting season (5). Climate change brings uncertainty to the future livelihoods of millions of smallholder coffee farmers around the world, who produce 70 percent of the world’s coffee (6). While world leaders dance around pretty statistical graphs of their carbon-cutting “achievements”, there is the underlying issue that global efforts to lower emissions will not have equal consequences across geographical locations. Poorer economies abundant in fossil fuel resources are pressured to implement policies that further increase their vulnerability and are left grappling to find quick coping strategies. Although it accounts for only a small percentage of global coffee production, East Timor is one of the most economically dependent on coffee. East Timor, the small-island nation 700km north-west of Darwin, has relied on its oil sector for economic development in recent decades, but now interest from foreign traders is depleting with global trends towards renewable energy. The coffee industry has been identified by the East Timor government as being a key opportunity for sustained economic growth and reduction of rural poverty. More than 18 percent of Timorese households rely on coffee production as their primary source of income (7). Coffee producers have a poverty rate of 47.9 percent, which is higher than the national rate of poverty, 40.3 percent (7). Many coffee-producing households are without electricity or access to clean water and regular meals. Figure 1: Distribution of coffee-selling households in Timor-Leste (7). Timorese Arabica coffee farmers today celebrate achieving yields their grandparents would have considered inadequate in the early 20th century during Portuguese occupation. This reflects how much the climate has changed across generations. Rain, once predictable to begin at the end of every November, is now inconsistent and reduced (1). Unfortunately, adaptive solutions often demand high investment and low reward in the initial implementation stages. Farmers may be reluctant to remove their aging, unproductive coffee trees and replant new ones for fear of losing a major source of income while waiting for financial output from the new growth (9). There is the temptation to instead plant new crops between existing ones, which exploits soil nutrients and harms coffee yields. Small short-term rewards also discourage poorer farmers from participating in collective reforestation projects (9). There is much work to be done to restore ecosystems devastated from rainforest clearances during Indonesian colonisation in 1975, which occurred mere months after independence from Portugal. Shade trees that characterise these tropical rainforests play important roles in supporting coffee growth. If farmers grow coffee crops amongst the rainforest, crops will benefit from wind shelter and rich soil nutrients (8). Shade reduces daytime air temperature and increases humidity. In the region of Baguia, the collaboration project WithOneSeed, (co-founded by Melbourne’s own ‘The Corner Store Cafe’ owners), actively alleviates poverty by restoring rainforests and granting farmers profits from carbon credit trades. Farmers plant an indigenous shade tree, carbon credits are purchased by foreign customers to offset fossil fuel emissions and a remuneration of 50cents per tree is given to farmers each year so long as the tree survives (10). WithOneSeed therefore provides rural coffee producers with income before trees mature and re-establishes tara bandu, customary resource management that sustained Timor Leste’s environment for centuries pre-colonisation. Organic beans are purchased from smallholder farms at a fair price by The Corner Store and roasted in Oakleigh. The supply chain is transparent and traceable and profits go towards funding WithOneSeed planting. Plus the coffee is good quality and grown without nasty chemicals! (11) Simple adaptive responses are also being made by coffee producers in the world’s fifth largest Arabica producer, Ethiopia (3). As Arabica has been said to originate here, it is perhaps unsurprising that 16 percent of the population rely on coffee for their livelihood. Figure 2: The main coffee growing areas of Ethiopia (3). In the case of a global temperature rise of 2.4 degrees Celsius, land areas suitable for coffee production in Ethiopia would be expected to decline by 21 percent (12). Resilience for smallholder Arabica producers now depends on creative solutions using limited technology and resources available to rural communities. Relocating farms to higher altitudes of Ethiopian highlands is one solution. But this transition comes at a cost for coffee producers in the form of social network losses. While climate conditions of higher land might be more suitable, other factors such as land tenureship rights and soil quality may pose new obstacles (13). As rain seasons shorten and dry seasons lengthen, Ethiopian coffee producers aim to boost irrigation by diverting nearby streams. This is an ancient and cost-effective solution that enables coffee to successfully be grown in areas classified unsuitable (3). Similarly, coffee producers are carrying out traditional techniques of mulching, where laying compost over soil conserves soil moisture (3). However, more government investment in supporting these adaptations is needed to keep ahead of global warming (3). Sustainable agriculture also needs to be met with fair prices. Many Ethiopian farmers do not have access to foreign traders who will pay premium prices that outweigh production costs. Coffee prices are determined by the international market, or “C price”, which is based on the theory that cost is proportional to global demand, with no consideration of quality or organic farming practices (14). This supports and encourages cheap, unsustainable agricultural practice because sustainable or not, farmers will receive the same revenue for their produce. To combat this, Ethiopian business CoQua, based in Addis Ababa city, facilitates opportunities for private producers to link with international clients and initiate direct lines of trade (14). Through CoQua, Melbourne’s Seven Seeds cafe were able to establish a trade relationship with private smallholder Ethiopian Arabica producers. Seven Seeds claim to pay 3.56 times the “C price” (14). Continue as we may to remain disconnected from the challenges of an environmentally fragile coffee industry, it is only a matter of time before global reduction makes noticeable impacts on Melbourne’s shielded society. What will happen when coffee stocks fail to meet Melbourne demand? Seven Seeds co-owner Mark Dundon told The Sydney Morning Herald that he predicts coffee prices will rise, despite general reluctance of consumers to spill more than one bank note from their wallets for a flat white (14). And why shouldn't we pay more for our hot beverages if producers vulnerable to food insecurity are paying more from the brunt of climate change? The following decades have a bitter outlook, but the recent pandemic outbreak enhanced our ability to envision rapid global disruptions where no corner of the world is excluded. Certainly a disruption to Melbourne coffee culture is a trivial issue in the grand scheme of things, but as consumers it is one worth considering now. The future for Melbourians to satisfy their cultural addiction balances dangerously on a series of environmental conditions being met in foreign highlands. While it’s true that being a “smart consumer” can feel like a matter of blind faith (how fair is fair trade?), favouring businesses that have ethical, direct lines of trade with smallholder producers is one small, immediate solution towards building a sustainable future for our treasured beans and those in the firing line of climate change. References: 1. Jack Board, “From crop to kopitiam, Asia's coffee is facing its biggest threat - climate change,” CNA, published 29 February 2020, https://www.channelnewsasia.com/asia/climate-change-coffee-prices-timor-leste-crops-1338741 2. Abaynesh Asegid, “Impact of Climate Change on production and Diversity of Coffee (Coffea Arabica L) in Ethiopia,” International Journal of Research Studies in Science, Engineering and Technology 7, 8 (2020): 31-38. 3. Kew Royal Botanic Garden, Coffee farming and climate change in Ethiopia, (London: The Strategic Climate Institutions Programme), 37, https://www.kew.org/sites/default/files/2019-01/Coffee%20Farming%20and%20Climate%20Change%20in%20Ethiopia.pdf 4. “How is Climate Change Impacting the Future of Coffee?,” TechnoServe Business Solutions to Poverty, published 16 September 2021, https://www.technoserve.org/blog/climate-change-impacting-future-coffee/ 5. Getachew Weldemichael and Demelash Teferi, “The Impact of Climate Change on Coffee (Coffea arabica L.) Production and Genetic Resources,” International Journal of Research Studies in Agricultural Sciences (IJRSAS) 5, 11, (2019): 26-34, DOI: http://dx.doi.org/10.20431/2454-6224.0511004. 6. Michon Scott, “Climate and Coffee,” Science Information for a climate-smart nation, published 19 June 2015, https://www.climate.gov/news-features/climate-and/climate-coffee 7. Brett Inder and Nan Qu, Coffee in Timor-Leste : What do we know ? What can we do ?, (Australia: Monash University), 17. 8. Simon P.J Batterbury, Lisa R. Palmer, Thomas R. Reuter, Demetrio do Amaral de Carvalho, Balthasar Kehi and Alex Cullen, “Land access and livelihoods in post-conflict Timor-Leste: no magic bullets,” International Journal of the commons, 9, 2, (2015): 619-647. 9. Lisa Walker, Understanding Timor Leste, (Dili: Swinburne Press, 2013), 22-158. 10. Andrew Mahar, “Meet the farmers helping to reforest Timor-Leste,” World Economic Forum, published 26 January 2021, Meet the farmers helping to reforest Timor-Leste | World Economic Forum (weforum.org) 11. “The Roastery,” The Corner Store, accessed November 2021, https://cornerstorenetwork.org.au/the-roastery 12. Cheikh Mbow et al., Climate Change and Land: an IPCC special report on climate change, desertification, land degradation, sustainable land management, food security, and greenhouse gas fluxes in terrestrial ecosystems, (2019), https://www.ipcc.ch/site/assets/uploads/sites/4/2021/02/08_Chapter-5_3.pdf 13. Yen Pham, Kathryn Reardon-Smith, Shahbaz Mushtaq and Geoff Cockfield, “The impact of climate change and variability on coffee production: a systematic review”, Climatic Change, 156, (2019): 609-630, The impact of climate change and variability on coffee production: a systematic review | SpringerLink 14. Dani Valent, “ 'The industry's at risk': the high price of cheap coffees,” published 31 May 2019, national/the-industry-s-at-risk-the-high-price-of-cheap-coffees-20190528-p51rti.html Previous article back to DISORDER Next article

< Back to Issue 4 Fool Me Once by Julia Lockerd 1 July 2023 Edited by Tanya Kovacevic and Elijah McEvoy Illustrated by Sonia Santosa I have rabies. I’m absolutely sure of it. I mean, I can't really tell, but that’s the silent killer, right? You don’t know you’re rabid till it’s all over, and you’re foaming at the mouth and biting your student tutor on the leg. Despite being completely safe here in Australia with its complete lack of rabies-having animals, I’m still pretty sure I’ve managed to catch it. Next week it will all be over for me and my tutor. Sorry, James. Of course, it’s not actually rabies that I’ve contracted, but a much more common condition: Medical Student Syndrome (1). Last week in my lectures, we learned all the ins, outs, and symptoms of the rabies virus. So, naturally, now we all have it. This health-related anxiety is a prime example of how our human brains can trick us into experiencing phantom symptoms. The same cognitive veil is used in clinical trials all over the world in order to test the efficacy of new drugs. We’ve all felt it. That moment when you question, ‘Is this real, or is my mind making its reality?’ We call this the placebo effect. The placebo effect is crucial to modern and historical experimental design. The ‘trickable’ nature of the human mind has changed the course of drug development as we know it. The effects’ success hinges on a patient's belief that they are receiving treatment for their ailment. The simple belief in a cure can often result in real physiological changes in an individual. This makes the placebo effect a very powerful tool in the development of new drugs for the market. In a placebo-controlled trial, half of the sample population will be blindly given a placebo, and the other half of the drug being tested. In order for a potential treatment to be considered effective, it must produce more significant results than the placebo group (2). We must improve our approach to designing and researching hypotheses. Can we use what we know about the placebo effect to make more accurate claims about modern pharmaceutical development? Well, in 2017, Dr. Sara Vanbheim of the Arctic University of Norway published a study that brought into consideration the possible effects of differing sexual characteristics on placebo efficacy (3). This idea could restructure the way experiments are designed going forward and potentially provoke a possible review of drugs already on the market. Is it possible that traditionally marginalised groups are underrepresented in the clinical trial process? Can we restructure experiments to be more inclusive? Are changes even really necessary? These questions were investigated through the compilation and calculation of placebo and nocebo effects on men and women over multiple previously conducted studies mostly centering around physical pain and the administration of analgesia. The term ‘nocebo’ defines the antithesis of a placebo (4), referring to adverse side effects a subject feels when given an inert version of the test drug. While placebos tend to have an analgesic effect, nocebos often cause negative effects or emotions when the subjects are told that they should expect/anticipate them. Before discussing any of these questions, it is worth noting that the Norwegian study focuses solely on classic sexual differences between cis-gender men and women. Though both keywords ‘gender’ and ‘sex’ were included in the study, research surrounding the specific effects of gender identity and gender-affirming therapies on placebos has not been thoroughly conducted as of 2023. It is with this focus that the following hypotheses are stated (3): “1) placebo responses would be stronger or more frequently observed in males than in females, 2) nocebo responses would be stronger or more frequently observed in females than in males, 3) verbally induced placebo responses would be more frequently observed in males than in females, and 4) conditioned nocebo responses would be more frequently observed in females than in males.” Results concluded that there was indeed a significant correlation between sex and placebo/nocebo effects when concerning pain relief. But what is truly fascinating is that while men received elevated levels of a placebo effect, such as reduced symptoms and analgesia, women were more susceptible to hyperalgesia and negative emotions. Those supposed ‘side effects’ appear to weigh more heavily on women (3). What does this say about how men and women process pain and information? The Norwegian study discusses the role of ‘psychophysiological mechanisms’ in pain pathways. Or, more simply, How stress and anxiety can affect the pain the brain perceives. In 8 of the 12 studies, men experienced significantly stronger analgesic effects from the placebo than women (3). It is plausible that men react more strongly to pain induced by stress hormones. This would explain why when taking a placebo, their anxiety level would decrease, and they would receive higher levels of analgesia than their female counterparts (3). Another study, upon which the Norwegian argument builds, investigates placebo delivery methods and their effect on perceived pain in men and women. In this study, men relied far more on verbal queues to provide analgesia, whereas women received a more significant effect from classic conditioning (5). These studies bring into question both the methodological and physiological effects of placebos on different sexes. What do these differences tell us about how men and women perceive the world? And what does this mean for the future of the placebo? The result of all of these studies is to show not whether placebos are bad or good, reliable or unreliable, but instead to highlight the differences in the physiological and psychological links when looking at different groups of people. At its core, a placebo is simply a trick of the brain, a psychological mirage. While the basis and reliability of placebos can be debated at length, their effect on the human brain teaches us something about ourselves societally. In all areas of medicine, the inclusion of people from all different backgrounds, genders, ethnicities, and ages is crucial so professionals know how to identify and treat various manifestations of a disease with grace and care. Now I know James responds better to verbal commands; I’ll be sure to tell him he has rabies the next time I see him. References Henning Schumann J. I contracted medical student syndrome. You probably will too. [Internet]. AAMC. [cited 2023 Jun 22]. Available from: https://www.aamc.org/news/i-contracted-medical-student-syndrome-you-probably-will-too Harvard Health Publishing. The power of the placebo effect - Harvard Health [Internet]. Harvard Health. Harvard Health; 2021. Available from: https://www.health.harvard.edu/mental-health/the-power-of-the-placebo-effect Vambheim S, Flaten MA. A systematic review of sex differences in the placebo and the nocebo effect. Journal of Pain Research. 2017 Jul;Volume 10:1831–9. National Cancer Institute NCI. Definition of nocebo effects [Internet]. www.cancer.gov . 2011. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nocebo-effect Enck P, Klosterhalfen S. Does Sex/Gender Play a Role in Placebo and Nocebo Effects? Conflicting Evidence From Clinical Trials and Experimental Studies. Frontiers in Neuroscience. 2019 Mar 4;13. Previous article Next article back to MIRAGE

About Us OmniSci Magazine is a science magazine at the University of Melbourne, run entirely by students, for students. Our team consists of talented feature writers, columnists, editors, graphics designers, social media and web development officers, all passionate about communicating science! Contributor Interviews for Issue 4 Editors-in-Chief Patrick Grave 2021-2023 Sophia Lin 2021-2022 Yvette Marris 2022-2023 Maya Salinger 2021-2022 Rachel Ko 2022-pres Felicity Hu 2021-2022 Caitlin Kane 2022-2023 Editors Ruby Dempsey Sam Williams Yen Jessica Nguy Breana Galea Khoa Tran Katherine Tweedie Andrew Lim Niesha Baker Mia Horsfall Ethan Newnham Irene Lee Hamish Payne Juulke Castelijn Caitlin Kane Natalie Cierpisz Column Writers Rachel Ko Grace Law Renee Papaluca Manthila Ranatunga Sonia Truong Lily McCann Zachary Holloway Irene Lee Issue 2 Feature Writers Sabine Elias Dominika Pasztetnik Hannah Savage Monica Blasioli Erin Grant Xenophon Papailiadis Hamish Payne Andrew Lim Caitlin Kane Mia Horsfall Hamish Payne Andrew Lim Illustrators & Designers Quynh Anh Nguyen Aisyah Mohammad Sulhanuddin Casey Boswell Jess Nguyen Friday Kennedy Janna Dingle Gemma Van der Hurk Rohith S Prabhu Social Media Officers Che McGuire Yvonne Le Janna Dingle Devia Kurniawan Web Dev Officers Sabine Elias Rebekka Krishtul Janna Dingle Devia Kurniawan Issue 1 Feature Writers Tanya Kovacevic Wei Han Chong Natalie Cierpisz Ashley Mamuko Ashleigh Hallinan Evelyn Kiantoro

< Back to Issue 2 Law and Order: Medically Supervised Injecting Centres Keeping people safe from the harms of drug use is an important public health goal, but some question the value of medically supervised injecting centres in improving health and community outcomes. by Caitlin Kane 10 December 2021 Edited by Tanya Kovacevic & Natalie Cierpisz Illustrated by Rachel Ko Medically supervised injecting centres (MSICs) are an exemption from the standard practices of law and order: instead of policing drug users, these facilities allow people to bring illegal drugs to dedicated, clean settings where they can legally inject themselves and receive medical care if required. Essentially, drugs like heroin and ice can be used in a safer environment often integrated with other health and welfare services. These centres aim to improve public health and amenity outcomes, but are criticised for facilitating drug use. Australia’s MSICs have been controversial since their inception. The first local MSIC opened in Kings Cross, Sydney in 2001, following a Vatican intervention to withdraw nuns and the arrest of a Reverend for opening a short-lived unsanctioned injecting facility (1,2). Local businesses and residents feared a nearby “safe haven for drug users” would accelerate rampant and disruptive public drug use and threatened last-minute legal action (3). The centre is still in operation and has now supervised more than one million injections without a single overdose fatality (1,4). Medical director Dr Marianne Jauncey explained how the Kings Cross centre saves lives in a discussion with the ABC this year (5). Yet before Australia’s second MSIC opened in Richmond, Melbourne in 2018, commentators continued to decry the proposition as accepting and passively encouraging drug use. Nationals MP Emma Kealy announced, "It sends the wrong message to our kids and effectively says we've given up on preventing drug use” (6). With consultation ongoing to establish a third Australian MSIC in the Melbourne city centre, it’s valuable to detangle the misconceptions around the effects of MSICs on communities and their value as public health tools. Much controversy around Australia’s MSICs centres on three concerns: the number of overdoses occurring on premises, the attraction of drug addicts to the areas, and the drain on public health resources. Examining the data collected by public health scientists demonstrates that these concerns are unfounded and supports the continued consideration of MSICs as effective public health interventions. WHAT EFFECT DO MSICS HAVE ON OVERDOSES? It’s critical to understand that MSICs are proposed for areas with heavy drug use, particularly use in public settings and causing medical emergencies like overdoses. At the turn of the millennium, the streets of Kings Cross were a major site of public drug use, overdoses, and ambulance callouts (7). In 2000, one spate of thirty-five Sydney overdoses, four fatal, occurred in a single twenty-four hour period (3). At the time, 10% of all drug overdoses in Australia occurred in Kings Cross (3). In response, the Kings Cross MSIC opened in 2001 following decades of mounting evidence in Europe. European drug injection centres had been operating since the 1970s, with growing official support through the 1990s in countries like the Netherlands, Switzerland, and Germany (2). Evaluations reported successful reductions in public nuisance, improved service access, and declining overdose deaths (2). Switzerland demonstrated annual overdose deaths halved in four years and a tenfold reduced chance of hospital admission in MSIC overdoses compared to overdoses on the streets (2,3). Similarly, the Richmond MSIC opened in 2018 as a response to the highest heroin death toll in sixteen years and record ice deaths in 2016, with the major drug market in Richmond considered the “epicentre of Melbourne’s heroin crisis” (8). It could be easy to criticise the overdoses occurring on the MSIC premises, but these overdoses predated the MSICs and prompted their opening after other strategies failed to address the crisis. As public health interventions, MSICs are most effective in areas with high densities of public drug use, like Kings Cross and Richmond, which is why these sites were chosen to house MSICs (7). A systematic review of studies covering a range of MSIC facilities, including Kings Cross, concluded that all facilities had a significant reduction in overdose deaths in their local area (9). Ambulance callouts for overdoses near Kings Cross decreased by 68% within six years of opening (9). In Richmond, emergency medical attendances to drug overdoses near the MSIC have decreased significantly. Only 30 of the 2657 overdoses treated at the MSIC in its first eighteen months led to ambulance attendance and there has been a 25% decrease in naloxone administration, a treatment for opioid overdose, by ambulances in the one kilometre radius of the MSIC (10). The impact of drug overdoses in these areas has been greatly mediated by the presence of the MSICs. In 2017, the Kings Cross MSIC celebrated one million injections with zero fatal overdoses (1). The lack of a single overdose death at these facilities despite the number of overdoses should be considered a mark of commendation (1,5,10,11). DO MSICS ATTRACT DRUG USERS TO THE AREA? A second concern is that MSICs attract drug addicts to the area in which they are situated. However, this misattribution of causality arises because MSICs are purposefully located in areas with pre- existing drug markets. Major drug markets create local hotspots of public injection as many drug users inject immediately to reduce withdrawal and avoid police attention (7). These areas of high public drug use became candidates for the establishment of MSICs because drug users already frequented the area. Before the MSIC opened, over 90% of ambulances attendances for overdoses in Kings Cross were within a 300 metre radius of the proposed MSIC location. The area was chosen for an MSIC because of the existing disruption caused by public drug use and overdose. Improving public amenity, such as decreasing encounters with discarded needles, drug injection and overdose, is one of the most important goals of MSICs (2,11). Despite initial outrage in Kings Cross, support for the centre among local businesses increased to 70% in 2005, and local perceptions were positive (11,12). Monitoring of the area found no increase in drug-related crime, dealing or loitering after the Kings Cross MSIC opened (11). This is also supported by more recent findings in 2017, that alongside improving local amenity and reducing ambulance callouts, the Kings Cross MSIC did not draw dealers and addicts to the area in a ‘honey pot’ effect (6). This was corroborated by a systematic analysis which found no increase in drug-related violence and crime related to MSICs in Sydney and Vancouver across the results of four studies (9). The same review concluded that MSICs do not promote drug use, crime, drug trafficking, or increase new drug users (9). Likewise, demand for the Richmond MSIC was created by the existing Richmond drug market and disruption to the community, with 46 of 49 local stakeholders found to support a proposed MSIC in a 2017 consultation (11). Alongside harm minimisation, one submission highlighted the “significant toll on health workers and members of the local community who have to deal with the aftermath of overdoses and for children to see people in public in such a terrible state” as motivating their support for establishing a Richmond MSIC (11). Since opening, concern that additional people would travel to use the centre was abated by findings that travel distance was a major reason for not attending the MSIC and residential information collected from Richmond MSIC users (10). Regarding public amenity, an evaluation found mixed results in its eighteen months of operation, with reduced sightings of public injections and incidents at the neighbouring school, but decreased perception of safety and community support for the MSIC (10). It remains to be seen how this trend develops with continued operation of the centre. DO MSICS DRAIN PUBLIC HEALTH RESOURCES? While the primary goal of MSICs is to reduce the harms associated with overdose and public drug injection, MSICs have broader public impact through integration with complementary social and medical services. People who inject drugs are subject to associated harms, ranging from increased risks of blood-borne diseases (HIV, HBV, HCV) and psychiatric disorders to homelessness, crime, and prostitution (2,10). This socially marginalised group often lacks adequate access to healthcare, despite the significantly increased risks of harm and death (9). Analysis of the Vancouver MSIC found the streamlined and preventative healthcare provided to drug users was quantifiably more effective and saved both millions of dollars and 920 years of life over 10 years (9). In 2008, an economic review of the Kings Cross MSIC determined that averted health costs alone made significant savings for the government, and the value of prevented deaths would pay for operating costs more than 30 times (13). Furthermore, unprecedented access to drug users can facilitate important research to investigate and validate public health issues and strategies. For example, a 2017 paper analysed the rates and severity of overdoses for illicit and prescription opioids with data from the Sydney MSIC, producing clinically salient research enabled by access to marginalised and vulnerable populations (14). Alongside reductions in ambulance callouts and overdose complications which are instead managed at the centre, MSICs can improve the reach and delivery of health and social services for drug users, including blood-borne disease screening, drug treatment and rehabilitation, and mental health counselling (9,10). Engagement with MSICs and integrated services promoted safer injecting practices, health and social service use, and entry to treatment programs. The overall proportion of MSIC-attending drug users in treatment programs was 93%, compared to 61% of first-time attendees at the facility, demonstrating the improved effectiveness of reaching drug users with healthcare programs (15). Across seven studies on drug user uptake of MSICs, 75% of drug users reported improvements in their behaviours regarding public amenity and safe injection (9). This effect was particularly strong for marginalised and at-risk attendees, like those who were homeless, Indigenous, had previously overdosed, and others with self-identified need (15). MSICs contribute massively to overall public health strategy, through both direct harm reduction and efficiently increasing access to existing services. BEYOND MEDICALLY SUPERVISED INJECTING CENTRES MSICs in Australia and across the world have been successful in achieving their objectives; reducing drug-associated harms and community exposure to public injection and overdose (9,12). The continued controversy around MSICs despite their established and validated success betrays widespread misunderstanding around the nature of addiction, the effective treatment and harm reduction for drug abuse. In 2017, despite the support of three coronial recommendations and the Australian Medical Association for a Richmond MSIC, MP Tim Smith asked, “Since when did we start rewarding people who break the law, since when did drug users become victims, we need to enforce the law" (6,8). Political discourse that distorts the goals of MSICs and distracts from their established efficacy only serves to stagnate evidence-based action and weaken Australia’s response to damaging drug use. While MSICs attract stagnating attention and controversy, public health issues around drug addiction and opioid dependency remain unaddressed (16). In Australia, prescription drug abuse causes ten times more overdose deaths than illicit drug abuse, and prescription opioids provides a pathway to the use of illegal opioids, like heroin and fentanyl (14,16). As seen in the 2017 investigation into the prevalence and consequences of opioid overdoses in the Kings Cross MSIC, prescription opioid injection is a significant form of harmful drug use (14). MSICs are a useful and effective tool to combat drug abuse, but are not intended to solve all drug-pertinent problems; they must be incorporated into broader public health and crime strategies (9). Drug abuse is a seriously complicated problem, so it makes sense to have misconceptions around the impacts of MSICs. Effective drug policy needs to consider MSICs as a component of a broader public health strategy and educate the public about responses to drug abuse. It’s critical for communities and decision-makers to stay informed and choose evidence-based strategies to address the public health and amenity goals around drug use. References: Alcohol and Drug Foundation. ‘Medically Supervised Injecting Centres - Alcohol and Drug Foundation’. Accessed 1 December 2021. https://adf.org.au/insights/medically-supervised-injecting-centres/. Dolan, Kate, Jo Kimber, Craig Fry, John Fitzgerald, David McDonald, and Franz Trautmann. ‘Drug Consumption Facilities in Europe and the Establishment of Supervised Injecting Centres in Australia’. Drug and Alcohol Review 19, no. 3 (2000): 337–46. https://doi.org/10.1080/713659379. Barkham, Patrick. ‘Sydney Gets Safe Haven for Drug Users’. The Guardian, 4 September 2000, sec. World news. https://www.theguardian.com/world/2000/sep/04/patrickbarkham. ‘20th Anniversary of Sydney’s Medically Supervised Injecting Centre’. Accessed 9 December 2021. https://www.uniting.org/blog-newsroom/newsroom/news-releases/20th-anniversary-of-sydney-s-medically-supervised-injecting-cent. The Kings Cross Supervised Injecting Facility Marks Its 20th Anniversary. ABC News, 2021. https://www.abc.net.au/news/2021-05-06/united-medically-supervised-injecting-centre-20th-anniversary/13332878. Carey, Adam. ‘“People Are Dying”: Trial of Safe Injecting Room Blocked by Andrews Government’. The Age, 7 September 2017. https://www.theage.com.au/national/victoria/people-are-dying-trial-of-safe-injecting-room-blocked-by-andrews-government-20170907-gycmiu.html. Uniting. ‘History of the Uniting Medically Supervised Injecting Centre’. Accessed 9 December 2021. https://www.uniting.org/community-impact/uniting-medically-supervised-injecting-centre--msic/history-of-uniting-msic. Willingham, Richard. ‘Renewed Calls for Safe Injecting Room as Victoria’s Heroin Death Toll Reaches 16-Year High.’ ABC News, 27 October 2017. https://www.abc.net.au/news/2017-10-27/spike-in-heroin-deaths-in-victoria-safe-injecting-rooms/9092660. Potier, Chloé, Vincent Laprévote, Françoise Dubois-Arber, Olivier Cottencin, and Benjamin Rolland. ‘Supervised Injection Services: What Has Been Demonstrated? A Systematic Literature Review’. Drug and Alcohol Dependence 145 (1 December 2014): 48–68. https://doi.org/10.1016/j.drugalcdep.2014.10.012. Department of Health. Victoria, Australia. ‘Medically Supervised Injecting Room Trial - Review Panel Full Report’. State Government of Victoria, Australia, 25 June 2020. http://www.health.vic.gov.au/publications/medically-supervised-injecting-room-trial-review-panel-full-report. Victoria, Parliament, Legislative Council, and Legal and Social Issues Committee. Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017. East Melbourne, Vic: Victorian Government Printer, 2017. Salmon, Allison M., Hla-Hla Thein, Jo Kimber, John M. Kaldor, and Lisa Maher. ‘Five Years on: What Are the Community Perceptions of Drug-Related Public Amenity Following the Establishment of the Sydney Medically Supervised Injecting Centre?’ International Journal of Drug Policy 18, no. 1 (1 January 2007): 46–53. https://doi.org/10.1016/j.drugpo.2006.11.010. SAHA. ‘NSW Health Economic Evaluation of the Medically Supervised Injection Centre at Kings Cross (MSIC)’, August 2008. https://www.uniting.org/content/dam/uniting/documents/community-impact/uniting-msic/MSIC-Final-Report-26-9-08-Saha.pdf. Roxburgh, Amanda, Shane Darke, Allison M. Salmon, Timothy Dobbins, and Marianne Jauncey. ‘Frequency and Severity of Non-Fatal Opioid Overdoses among Clients Attending the Sydney Medically Supervised Injecting Centre’. Drug and Alcohol Dependence 176 (1 July 2017): 126–32. https://doi.org/10.1016/j.drugalcdep.2017.02.027. Belackova, Vendula, Edmund Silins, Allison M. Salmon, Marianne Jauncey, and Carolyn A. Day. ‘“Beyond Safer Injecting”—Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility’. International Journal of Environmental Research and Public Health 16, no. 11 (January 2019): 2032. https://doi.org/10.3390/ijerph16112032. Fitzgerald, Bridget. ‘Drug Overdoses Killed More than 2,000 Australians for the Fifth Consecutive Year, Report Finds’. ABC News, 31 August 2020. https://www.abc.net.au/news/2020-08-31/more-than-2000-australians-lost-their-lives-due-to-overdose-2018/12612058. Previous article back to DISORDER Next article

< Back to Issue 4 Why Our Concept of Colours is Broken by Selin Duran 1 July 2023 Edited by Tanya Kovacevic and Megane Boucherat Illustrated by Aizere Malibek The world that surrounds us is made from a combination of three main colours: red, yellow and blue. Known as the primary colours, it's the first thing we learn in primary school art class. In illusions, however, our concept of colours becomes warped and fails us. The only question is how do we fix it? Take the infamous colour-changing dress of 2015. This dress became an internet sensation due to its ambiguity of colour with the major question being “Is the dress black and blue or white and gold?” The dress, despite causing many online debates, is actually black and blue. Nevertheless this debate raises an important question about colours. Why do we see different colours in the same image? Let's begin with colour theory. Colour theory is a set of guidelines that artists use when mixing colours within the spectrum. With the intention of provoking different psychological responses, colours are used to either complement or contrast one another [1]. We see this through the infamous dress - with black and blue complimenting each, then gold and white. Our highly subjective perception allows us to see visually appealing combinations of colours juxtaposed to contrasting combinations. However, what we also need to consider are the light sources being used. Ranging from natural light to blue light and other artificial lighting, the light that we are exposed to can alter our perspective of colour. On our devices, we see colours through a series of red, green, and blue pixels that combine to make new colours for every image that we see [2]. Similarly, the frequent manipulation of our devices’ brightness also contributes to different colours being shown on the screens. These are the primary reasons why the famous dress was perceived so differently by everyone: each device shows a different version of the same colour depending on its display settings, which affects how many red, green and blue pixels there are. In addition to the colour theory, another effect— the Bezold Effect—is at its peak with the infamous dress. The Bezold Effect is an optical illusion where a colour’s appearance is affected by the presence of colours that surround the object [3]. For this dress, it’s seen through the shadows that form on and around the bodice. With brighter surroundings, such as the sun or an overly brightened screen, the blue from the dress appears gold to the eye, while the black appears white. The dress reverts to its original colours when the screen is darkened or artificial light is used. Circling back to colour theory, the changes in colours aren’t randomly allocated: they are opposing colours of the colour wheel. The wheel is a visual illustration of colours arranged by their wavelength, used to display the relationship of primary colours to their corresponding secondary colours [4]. With blue contrasting a yellow or gold, the changes in lighting perfectly display the contrasting colours on the wheel. The fascinating nature of colours is not something we can fix. In the era of digital displays and evolving technologies, we can’t see things the “right” way because there is no notable “right” or “wrong” way to look at the world. The dress is just one of those illusions that changes depending on the context and surroundings that it’s placed in. You can manipulate these colours and force them to change by physically changing the brightness on a device. So out of curiosity, I decided to conduct a little experiment of my own through an Instagram poll to see what my friends thought of this dress. While only 37 people participated, it was still fun to see what would happen with the votes; however, I was surprised to see the results after 24 hours. I expected a majority to choose the “real” colour of the dress, since the dress has been around in the media for a while and the answer is also online, but people still had contrasting opinions about the dress. With only 54% of people seeing black and blue and 46% white and gold, I began questioning our vastly different perceptions. The answer always seemed obvious as the dress was always black and blue not white and gold but that didn’t mean that other people saw what I saw. My favourite response came from a friend who saw the dress as blue and gold and after that, my opinion changed. For me, the dress is now blue and with tints of gold and I can’t see it any other way. This truly goes to show that there’s more behind the dress than what meets the eye. When I first saw the image my brightness was at the lowest it could possibly be and now after looking at the image enough, it’s just blue and gold. The ambiguity of this image is what makes the dress the best example of a real-life illusion. Other colour combinations act the same way in different lighting, but what we see is completely dependent on our perceptions, and every now and then, it’s always fun to put up a debate. References Eliassen MM. Colour theory. Salem Press Encyclopedia [Internet]. 2023 Jan 1 [cited 2023 May 13]; Available from: https://discovery.ebsco.com/linkprocessor/plink?id=30f4180b-d38d-38e6-95df-fcf469ab5c8a Mertes, A. (2021, February 23). Why Computer Monitors Display the Same Colors Differently . https://www.qualitylogoproducts.com/ . https://www.qualitylogoproducts.com/promo-university/why-monitors-display-different-colors.htm#:~:text=The%20pixels%20are%20in%20some,shows%20up%20on%20the%20screen Lasikadmin. (2022, June 2). What is Bezold Effect? | Useful Bezold Effect. LASIK of Nevada. https://lasikofnv.com/blog/test-your-vision-by-bezold-effect/#:~:text=What%20is%20the%20Bezold%20Effect,one%20to%20the%20human%20eye Understanding color theory: the color wheel and finding complementary colors . (n.d.). https://www.invisionapp.com/inside-design/understanding-color-theory-the-color-wheel-and-finding-complementary-colors/ Previous article Next article back to MIRAGE

< Back to Issue 7 Peaks and Perspectives: A Word from the Editors-in-Chief by the Editors-in-Chief 22 October 2024 illustrated by Ingrid Sefton In geometry, an apex may refer to the highest point of a solid figure, such as a pyramid. Move to the fields of ecology and evolution, and we find apex predators, overseeing population dynamics atop of the food chain. We too find ourselves situated at an apex position in society – observing, experimenting with, and utilising the world at our feet for scientific innovation and headway. Common amongst these apexes in science is unsurprisingly the emphasis on reaching soaring heights and breathtaking summits. We strive to reach these peaks, endpoints that are perceived to signal scientific greatness and knowledge. We create, we innovate, we explore – all with this vision in mind. Yet, this is not, or rather, should not be the “why” for scientific endeavour. Implicit in reaching the highest point of something is the notion that there is no further to climb. That upon reaching an apex, all that remains is to precariously balance upon this peak and hope not to misstep, tumbling down from great heights. Scientific curiosity and a yearning to understand the science underpinning our existence is not about reaching the envisioned apex. It is instead defined by the steps climbed by us and our predecessors in our journey towards discovery, and in turn, the steps that remain untrod and paths that remain uncharted. The routes we are yet to take will be forever changing. Piloted by the evolving foci of our society, where and how we may next seek to innovate remains undetermined. Infinite possibilities abound. With a birds-eye view, Apex visualises the new levels of human-tech connectivity, ills of antimicrobial resistance, and the fringes of outer space that loom on the horizon; with it, encouraging readers to envisage where the next steps may lie. Yet alongside these perspectives of the expansive, limitless world, Apex invites reflection and hypotheticals. Taking time to pause from the unfaltering upward march of innovation, this issue embraces the breathtaking view of where we are now. Apex guides us to consider time-old traditions and technicalities from a new perspective, celebrating those who have paved the way to the peaks of modern science. Wandering within, across and between disciplines of Science, it is these ruminations along the way that enrich the journey. After all, what is scientific advancement without knowing what we do not know? In the words of Sir Isaac Newton, it is by standing on the shoulders of giants that we hope to see further. So come along, and revel in the expansive view. Let the heights of scientific innovation inspire you, but don’t let such peaks constrain you. Previous article Next article apex back to

< Back to Issue 6 A Brief History of the Elements: Finding a Seat at the Periodic Table by Xenophon Papas 28 May 2024 Edited by Arwen Nguyen-Ngo Illustrated by Rachel Ko What are we made of and where did it all come from? Such questions have pervaded the minds of scientific thinkers since ancient times and have entered all fields of enquiry, from the physical to the philosophical. Our best scientific theory today asserts that we’re made of atoms, and these atoms come in different shapes and sizes. Fundamentally, they can be described by the number of subatomic particles (protons, neutrons, and electrons) they contain (Jefferson Lab, 2012). Neatly arranged in a grid, these different elements form the periodic table we know and love today; but it was not always this way. The story of how the periodic table of elements came to be harks back to Ancient Greece and winds its way through the enlightenment into the 20th century. It is an unfinished story of which we are at the frontier of today: in search of dark matter and the ultimate answer to what the universe is made of. We may never know for sure exactly what everything in existence consists of, but it’s a pursuit our earliest ancestors would be proud to see us follow. Thales was first in the ancient Greek-speaking world to postulate about the origins of all material things. He theorised that all matter in the universe was made up of just one type of substance – water – and any other forms of solids, liquids and gases were just derivatives thereof. This idea was not initially opposed, given Thales was one of the earliest of the Ancient Greeks to pursue such questions of a scientific nature. Afterall, he’s remembered today as the “Father of Science” in the Western world. As Thales was from Miletus, a city on the coast of the Ionian Sea in modern day Türkiye and part of Magna Graecia in the 6th cent BC, it is not hard to imagine that water was a crucial aspect in trade, agriculture, and daily life at the time. However, this seemed to oversimplify the matter to some of his contemporaries. Empedocles, who was considered more a magician than a philosopher, revised this mono-elemental theorisation in the 5th Century BC. He proposed four basic substances from which all others were made (Mee, 2020). We know them today famously as the four classical elements: Earth, Air, Water and Fire. This asserted a fundamental principle of “fourness”, encompassing the cardinal directions in the Western world during this time. Interestingly, concurrent to this other traditions such as those in China acknowledged five elements and compass points instead. A generation later to Empedocles’ work, Plato embraced his “fourish” formulation. Being heavily influenced by mathematics as the medium through which we make reason of the natural world, Plato related each of these elements to a mathematical object: a convex, regular polyhedron in three-dimensional Euclidean space, otherwise known as a Platonic solid. Earth was associated with the cube, air with the octahedron, water with the icosahedron, and fire with the tetrahedron. Lastly, the most complicated solid, the dodecahedron – itself made up of composite regular polygons – was associated with the makeup of the constellations and the Heavens themselves, their workings said to be unfathomable by human minds (Ball, 2004). His student, Aristotle, ran with this idea and devised a clever way to break up the elements based on their "qualities”, akin to a first periodic table. These binary roles were hot and cold, wet and dry, with an element containing just two of these qualities each. According to Aristotle, each of these elements could be converted to the other by inverting one of their qualities, seemingly bringing about an early form of alchemy. To these four elements, he also appended a fifth - aether or “pure air” - to fill the expanses of the heavens, which also became associated with the fifth Platonic solid. In the Western World, Aristotle’s word was taken as doctrine for a very long time owing greatly to the fall of Rome and the cultural instability thereafter. Where Europe plummeted into the Dark Ages with a reverence for the scholars of antiquity, scientific and literary endeavour flourished in the Middle East – the word alchemy itself having etymologically Arabic roots. It was not until the late 17th century that the likes of Galileo, Newton, and Descartes revived Western scientific pursuit, and sought to understand how the natural world arranged itself. In the 18th century, new discoveries were being made on the frontiers of science in major cities throughout Europe. In 1772, in Paris, Antoine Lavoisier began work on combustion of materials like phosphorus and sulphur. Lavoisier concluded that if something decomposes into simpler substances, then it is not an element. For example, while water can be turned into a gas when passed over hot iron and is therefore not an element, oxygen and hydrogen are indeed elemental. English chemist John Dalton took after Lavoisier and in 1808 began to arrange elements spatially into a chart, accounting for their various properties. In Strasbourg 1827, Wolfgang Döbereiner recognised that groups of threes arose from the list of elements which behaved similarly, known as “Döbereiner's triads" (Free Animated Education, 2023). John Newlands in 1866 put forward the “Law of Octaves”. Elements with similar properties ended up at regular intervals, dividing the elements into seven groups of eight – hence octaves. However, this method of dividing up the elements broke down in some special cases. Now turning to St. Petersburg, Russia, in February of 1869. Dmitri Mendeleev sits at his desk, with a mess of cards covering the surface of his working space. The professor of chemistry rearranges these elemental cards like a jigsaw puzzle, arranging and rearranging them to align them in accordance with their properties. Supposedly after coming to him in a dream, a pattern emerged. Mendeleev saw the ability for the simple tabulation of the elements based on their atomic number and hence their common properties. This newfound tool, based on Lavoisier’s work a century prior, allowed for the prediction of properties of elements which had not even been discovered yet. Elements which Mendeleev believed to exist, even though they presented as empty gaps in the grid structure of the periodic table. Within just twenty years, Mendeleev’s prediction of the existence of such elements like gallium, scandium, and germanium had been validated with experimental fact. All of this was predicted without knowledge of the true reason for similarities of elemental properties – the electron shell arrangement at a subatomic level. Mendeleev had totally changed the way chemists viewed their discipline and has been immortalised for perhaps the greatest breakthrough work in the history of chemistry (Rouvray, 2019). Today we recognise that all the elements in the universe have origins in the high-pressure hearts of stars. Like a hot furnace, they churn out heavier and heavier elements under their immense internal pressures. Once this life cycle comes to an end, the star erupts into a fiery supernova, releasing even more of the heavier elements we see further down the periodic table. In the last 75 years, scientists have added an additional 24 elements to the periodic table, some of which are so difficult to produce that their half-lives last only a few fractions of a millisecond before decaying away to nothing (Charley, 2012). This begs the question; how do we find new elements? Elements can be created via either fission, splitting apart a heavier atom, or fusion, binding two bodies of atoms together. The heavier an element, that is, the more protons and neutrons in its nucleus, the more unstable it is. Hence it is with great difficulty that scientists attempt to churn out new elements from large particle accelerators, by colliding and combining elements into new ones (Chheda, 2023). The story of physical matter is just one aspect in the search for what “everything” is made of. Dark matter and dark energy – so named because they do not interact with light – have been found to drive the expansion of the universe and the rotation speeds of galaxies. We know remarkably little about these substances, given that they make up around 95% of the total mass of the universe! Without a doubt, we have only just begun the journey to find out what makes up the universe around us. References Chheda, R. (2023, March 31). Can we add new elements to the periodic table? Science ABC. https://www.scienceabc.com/pure-sciences/can-we-add-new-elements-to-the-periodic-table.html Charley, S. (2012). How to make an element. PBS. https://www.pbs.org/wgbh/nova/insidenova/2012/01/how-to-make-an-element.html Free Animated Education. (2023, February 10). Perfecting the periodic table [Video]. YouTube. https://www.youtube.com/watch?v=7tbMGKGgCRA&ab_channel=FreeAnimatedEducation Jefferson Lab. (2012, November 20). The origin of the elements [Video]. YouTube. Ball, P. (2004). The elements: A very short introduction . Oxford University Press. Mee, N. (2020). Earth, air, fire, and water. In Oxford University Press eBooks (pp. 16–23). https://doi.org/10.1093/oso/9780198851950.003.0003 Rouvray, D. (2019). Dmitri Mendeleev. New Scientist. https://www.newscientist.com/people/dmitri-mendeleev Previous article Next article Elemental back to

Issue 1: Science is Everywhere Foreword from Dr Jen Marti n From the Editors-in-Chief Hear from the founder and leader of the UniMelb Science Communication Teaching Program! A few words from our four Editors-in-Chief on the inaugural issue of OmniSci Magazine! 2 minute read 2 minute read Columns The body, et cetera Conversations in science Chatter Wiggling Ears By Rachel Ko Let’s take a trip down evolution lane to uncover the story behind everyone’s favourite useless party trick: ear wiggling. 3 minute read Behind the Scenes of COVID-19 with Dr Julian Druce By Zachary Holloway In conversatio n with Dr Julian Druc e. 6 minute read Silent Conversations: How Trees Talk to One Another By Lily McCann What do trees talk about? 5 minute read Science Ethics Cinema to Reality Humans of UniMelb Should We Protect Our Genetic Information? By Grace Law How much is our genetic and biometric data worth? And why are others so keen to get their hands on it? Can We Build the Iron Man Suit? By Manthila Ranatunga Ever wondered what it takes to build the Iron Man suit? Research - Is it For Me? By Renee Papaluca Hear from current research students about their experiences studying science at UniMelb. 4 minute read 4 minute read 4 minute read The Greenhouse Unpacking the Latest IPCC Report — What Climate Science is Telling Us By Sonia Truong Unpacking the latest UN IPCC report on the science behind climate change. 5 minute read Features Our Microbial Frenemies By Wei Han Chong Diseases and pandemics have always been the source of great disasters throughout history, so why don't we do away with them? 7 minute read Where The Wild Things Were B y Ashleigh Hallinan Biodiversity loss is perhaps just as catastrophic as climate change, so let's consider the role of ecosystem restoration in battling this ecological emergency. 6 minute read Understanding the Mysterious Science of Sleep By Evelyn Kiantoro Sleep, our favourite way to wind down and relax. But why do we sleep? Moreover, what are dreams? 6 minute read The Rise of The Planet of AI By A shley Mamuko When does tech become fully integrated into our lives? 7 minute read The Intellectual’s False Dilemma: Art vs Science By Natalie Cierpisz The age-old debate once again resurfaces. Art and science. Two worlds collide 6 minute read Climate Change, Vaccines & Lockdowns: How and Why Science Has Become a Polarising Political Debate By Mia Horsfall How should scientific research and political legislation interact, and what role should they play in public discourse? 6 minute read Sick of Lockdown? Let Science Explain Why. By T anya Kovacevic The mechanisms behind lockdown fatigue - and how to treat it. 6 minute read Let's Torque Competition Winner Bionics: Seeing into the Future By J oshua Nicholls Let's explore the ground-breaking technology that could help Australians suffering from visual impairment. Let's Torque is the premier science communication organisation taking STEM to Victorian schools and undergrad students. They host a science communication competition annually. 5 minute read Let's Torque website

< Back to Issue 7 Staying at the Top of Our Game: the Evolutionary Arms Race by Aizere Malibek 22 October 2024 edited by Rita Fortune illustrated by Aizere Malibek Organisms have been competing for biological domination since the beginning of life. Evolutionary adaptations arise from genetic mutations, which propel biodiversification and allow organisms with favourable traits to survive and reproduce. This is the foundation of Charles Darwin’s Theory of Evolution, explaining the rise of antimicrobial resistance and contagious viruses, while also offering solutions to these threats in public health and medicine. Mutations in the DNA of pathogens allow them to adapt to our immunological defences and invade our bodies. Conversely, the variation in our immune cells allows us to detect and defend against pathogens as a counter-adaptation. Medicine has advanced dramatically in the recent decades, with novel vaccines, antivirals and antibiotics being developed quicker than ever before. Unfortunately, persistent pathogens have found a way to survive attacks from our immune systems and drugs, making it difficult to devise an effective cure for these infections. Take HIV, for instance: the virus activates programmed cell-death in our CD4+ T immune cells and alters their metabolism as a survival mechanism (Gougeon, 2003; Palmer et al., 2016). In turn, this directly reduces the immune system’s ability to defend against the virus. This is further complicated by the high mutation rate of HIV, leading to rapid resistance to various treatment options (Gupta et al., 2018). Fortunately, scientific discoveries are helping us develop solutions for infectious diseases. It was found that HIV is susceptible to immune responses in its initial immature stages, which has become a target of the current pursuits in vaccine development for the virus (Picker et al., 2012). Vaccines are beneficial in these cases because they expose memory cells in order to inactive microbial antigens, which are a key cell involved in our active immune responses. This allows our bodies to tackle the pathogens more efficiently, reducing the symptoms and long-term effects of infection. Another emerging treatment option is through CRISPR-Cas9 technology. Originally discovered as a bacterial defence system against viruses, CRISPR allows scientists to precisely edit genes. This technology is being explored not only for its potential to correct genetic disorders, but also as a weapon against pathogens. Researchers are looking into using CRISPR to target viral DNA in infected human cells, cutting it out before the virus can replicate (Mengstie & Wondimu, 2021). If successful, CRISPR could be a game-changer in the fight against diseases like HIV, influenza, and even the next pandemic. However, HIV is just one example of this ongoing evolutionary arms race between pathogens and humans. The phenomenon isn’t restricted to just viruses; bacteria and fungi have also become significant opponents. The rise of antibiotic resistance in bacteria is an alarming and rising public health issue today. Antibiotics are increasingly losing their efficacy due to misuse and overprescription. Pathogens like Escherichia coli ( E. coli ) and Staphylococcus aureus ( S. aureus ) have developed multiple resistance mechanisms, including the production of enzymes that break down the antibiotic molecules before they can exert their effect (Reygaert, 2018). Methicillin-resistant Staphylococcus aureus (MRSA) is a prime example of antibiotic resistance. Initially, methicillin was developed to treat penicillin-resistant strains of bacteria. However, as methicillin became widely used, new strains of S. aureus emerged that could resist the potent drug. MRSA infections are now incredibly difficult to treat and pose a serious public health threat, particularly in hospitals and healthcare settings where immunocompromised patients are most vulnerable (Collins et al., 2010). Vaccines are not as effective against bacteria and fungi due to the more complex structures of these organisms. So how do we stay ahead in this race? One promising area of research is the development of next-generation antibiotics and antivirals. Researchers are now investigating bacteriophages—viruses that specifically infect bacteria—as a potential solution to antibiotic-resistant infections. These phages, which evolve alongside bacteria, could be used to target and destroy harmful bacterial strains without the collateral damage caused by traditional antibiotics (Plumet et al., 2022). While scientific innovation is key to staying ahead in the evolutionary arms race, public health policies play an equally important role. Misuse of antibiotics, for instance, has significantly accelerated the rise of antibiotic-resistant bacteria outside healthcare settings (David & Daum, 2010). Governments and healthcare organisations are now pushing for stricter regulations on antibiotic prescriptions and promoting the responsible use of these drugs. Global collaboration is also essential. Pathogens don’t respect national borders, and the spread of infectious diseases is a global issue. Initiatives like the World Health Organisation’s Global Antimicrobial Resistance Surveillance System (GLASS) are crucial in monitoring and controlling the spread of resistant pathogens worldwide. By sharing data and resources, countries can better coordinate their responses to emerging threats, mitigating the risks posed to global health. The dynamic shifts in power between humans and pathogens continues to unfold in this evolutionary arms race. While scientific innovation is allowing the development of new tools, from vaccines to gene-editing technologies, we must also adopt policies that promote responsible drug use and global cooperation. In this race, staying at the top of our game requires constant vigilance, innovation, and adaptation—because pathogens certainly aren’t slowing down. The stakes are high, but with continued research and collaboration, we have the potential to maintain the upper hand in this ever-evolving battle for survival. References Collins, J., Rudkin, J., Recker, M., Pozzi, C., O'Gara, J. P., & Massey, R. C. (2010). Offsetting virulence and antibiotic resistance costs by MRSA. Isme Journal, 4(4), 577-584. https://doi.org/10.1038/ismej.2009.151 David, M. Z., & Daum, R. S. (2010). Community-Associated Methicillin-Resistant Staphylococcus aureus : Epidemiology and Clinical Consequences of an Emerging Epidemic. Clinical Microbiology Reviews, 23(3), 616-+. https://doi.org/10.1128/cmr.00081-09 Gougeon, ML. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3 , 392–404 (2003). https://doi.org/10.1038/nri1087 Gupta, R. K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Forero, L. A., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., Dzangare, J., Hone, S., Hang, Z. Z., Garcia, J., Garcia, Z., Marchorro, P., Beteta, E., Giron, A., Hamers, R., . . . Bertagnolio, S. (2018). HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infectious Diseases, 18(3), 346-355. https://doi.org/10.1016/s1473-3099(17)30702-8 Mengstie, M. A., & Wondimu, B. Z. (2021). Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing. Biologics-Targets & Therapy, 15, 353-361. https://doi.org/10.2147/btt.S326422 Palmer, C. S., Cherry, C. L., Sada-Ovalle, I., Singh, A., & Crowe, S. M. (2016). Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis. EBioMedicine, 6, 31–41. https://doi.org/10.1016/j.ebiom.2016.02.012 Picker, L. J., Hansen, S. G., & Lifson, J. D. (2012). New Paradigms for HIV/AIDS Vaccine Development. In C. T. Caskey, C. P. Austin, & J. A. Hoxie (Eds.), Annual Review of Medicine, Vol 63 (Vol. 63, pp. 95-111). https://doi.org/10.1146/annurev-med-042010-085643 Plumet, L., Ahmad-Mansour, N., Dunyach-Remy, C., Kissa, K., Sotto, A., Lavigne, J. P., Costechareyre, D., & Molle, V. (2022). Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials. Frontiers in cellular and infection microbiology, 12, 907314. https://doi.org/10.3389/fcimb.2022.907314 Reygaert, W. C. (2018). An overview of the antimicrobial resistance mechanisms of bacteria. Aims Microbiology, 4(3), 482-501. https://doi.org/10.3934/microbiol.2018.3.482 Previous article Next article apex back to

Message from the Editors in Chief By Caitlin Kane, Rachel Ko, Patrick Grave, Yvette Marris 23 March 2022 Edited by the Committee Illustrated by Quynh Anh Nguyen Another year in science has passed, with 2022 disappearing into 2023. With a mandated return to campus life at the University, there seems a tangible break from the past three years of lockdowns, isolation and online existence. Over the summer holidays, four of our wonderful OmniSci contributers—Andrew, Julia, Lily and Yvette—have written about science that has made a mark in 2022, with topics spanning DNA of the ancient past to the future of art crafted by artificial intelligence. Our writers were supported by editors, Tanya and myself, and the cover and article art for this issue has been created by Quynh Anh. Thanks also goes to our behind-the-scenes events duo, Andrew (again!) and Aisyah, who have been working hard on promotion to showcase the work of our team on this mini-issue, and our treasurer-secretary, Maya, who keeps us all in line. On behalf of the whole team, we're incredibly excited to share our summer issue, 2022: A Year in Science. If you would like to support our work, you can sign up as a member, join our mailing list or get in touch at omniscimag@gmail.com—all this and more on our About Us page. Most importantly, please read on! Previous article Next article

Issue 7: Apex 22 October 2024 This issue surveys our world from above. So come along, and revel in the expansive view - have a read below! Editorial Peaks and Perspectives: A Word from the Editors-in-Chief by the Editors-in-Chief A word from our Editors-in-Chief. Corals A Coral’s Story: From thriving reef to desolation by Nicola Zuzek-Mayer Nicola sheds light on the devastating future faced by our coral reefs, with the effects of anthropogenic climate change far from having reached its peak. Humans vs Pathogens Staying at the Top of Our Game: the Evolutionary Arms Race by Aizere Malibek As nations vie for military supremacy, Aizere covers a microscopic competition between humans and the microbes evolving strategies against our defences. Seeing Space Interstellar Overdrive: Secrets of our Distant Universe by Sarah Ibrahimi Embark on an epic journey as Sarah explores the cosmic mysterious being revealed by NASA's James Webb Space Teloscope. Fossil Markets Fossil Markets: Under the Gavel, Under Scrutiny by Jesse Allen Diving into the wild world of fossil auctions, Jesse prompts us to ask: who is the real apex predator, the T-rex or hedge-fund billionaires? Cancer Treatments Tip of the Iceberg: An Overview of Cancer Treatment Breakthroughs by Arwen Nguyen-Ngo Icebreakers. Follow Arwen as she recounts the countless stories of the giants before us, who carved a path for our cancer research today. Triangles Pointing the Way: A Triangular View of the World by Ingrid Sefton Guiding us through land, seas and screens, Ingrid explores this humble 3-sided shape as a vital tool of modern society and its many fascinating uses. Anti-ageing Science Timeless Titans: Billionaires defying death by Holly McNaughton From billionaire-backed pills to young blood transfusion, Holly traverses the futuristic world of anti-ageing and asks: what happens when death is no longer inevitable? Brain-computer Implants Neuralink: Mind Over Matter? by Kara Miwa-Dale Would the ability to control a computer with your mind bolster possibilities or bring harm? Kara visualises a possible future under the Neuralink implant. Fish Morphology Designing the perfect fish by Andy Shin With a splash of creativity, Andy concocts the ultimate 'Frankenfish' by investigating the traits that allow fish to flourish in their aquatic environments. Commercial Aviation Soaring Heights: An Ode to the Airliner by Aisyah Mohammad Sulhanuddin Settle in and take a round trip with Aisyah through the evolution of commercial aviation, from the secrets of aircraft cuisine to the mechanics of staying afloat.

< Back to Issue 7 Timeless Titans: Billionaires defying death by Holly McNaughton 22 October 2024 edited by Arwen Nguyen-Ngo illustrated by Esme MacGillivray Humans are destined to face an unavoidable end, but what if we weren't? What if humans could push the boundaries of death and become "un-ageable"? What would be the consequences if the world's top apex predators became immortal? The concept of anti-ageing and the quest for eternal life is not new. Cleopatra supposedly bathed in donkeys’ milk to reduce wrinkles. The first emperor of the Qin dynasty (221-206 B.C.), tried to achieve immortality by taking pills. Unfortunately for him, the key ingredient was the highly toxic substance—mercury. In 16th century France, members of the nobility would drink gold to preserve youthful looks. Much like in the past, today’s leading figures in the anti-ageing field are those with power and wealth. Today, the same obsessive quest for youth persists, but now it is backed by cutting-edge science and more importantly, staggering wealth. This article delves into the latest anti-ageing trends—pills, specialised diets, and more—championed by modern-day billionaires. We’ll explore the innovations they fund, and more provocatively, what it means for humanity when death is no longer inevitable. Anti-ageing pills The first “key” to anti-ageing is metformin, which dates to the1920s and was first discovered in the medicinal herb Galega officinalis . It lowers blood sugar levels and is taken as a popular treatment for type 2 diabetes (Bailey, 2017). Metformin works by tricking your body into thinking there is not enough energy, lowering blood glucose levels, and helping the insulin your body makes to work better. In a 2014 clinical study, patients with type 2 diabetes initiated with metformin had longer survivals than non-diabetics who did not receive the drug (Bannister et al. 2014). Although this is a correlation, not causation, some studies state Metformin has increased lifespan in mice (Martin-Montalvo et al., 2013). While we are anticipating the results of a trial on the effects on humans, and particularly the effects on non-diabetic lifespan, some are already convinced by the results from preliminary studies, such as Byran Johnson. Johnson is a self-proclaimed Professional Rejuvenation Athlete and founder of Project Blueprint. The Blueprint protocol is an extensive regimen of exercise, health tests, supplements, and a strict diet, to reverse biological age. Bryan has been following the protocol since 2021 and has successfully slowed down his rate of ageing to 0.76, meaning that for every year, Bryan is only ageing 277 days. Luckily, it only costs him 2 million a year. As part of the protocol, Bryan takes several prescription drugs daily, including metformin twice a day and rapamycin. Rapamycin is another promising “key” anti-ageing drug that works as a mTOR inhibitor. mTOR is a key component in cell growth, proliferation and survival. By inhibiting mTOR, cell growth and protein synthesis processes are slowed, thus reducing the chance of pathology (disease and/or injury) of cells and tissues. It has been shown to extend the lifespan of mice, yeast, worms and fruit flies (Harrison et al., 2009) and in 2018, elderly humans given rapamycin showed promising results with improvement in immune function and decreased infection rates (Mannick et al., 2018), which could ultimately lead to longer lifespans. Young blood transfusion Throughout history, blood has been a popular anti-ageing remedy. In the 15th century, Pope Innocent VIII drank the blood of three young boys, to heal his ailments (Scott & DeFrancesco, 2015). It did not work. The term “Young Blood transfusion” is now used to refer to the practice of transfusing blood from a young person into an older one to tackle age-related diseases. The rationale comes from parabiosis experiments. Parabiosis is the anatomical and physiological union of two organisms, and in the 1950s it was performed on two mice, surgically stitched together. A month after the procedure, the older mice showed rejuvenation (Conboy et al., 2005). In 2017, a new startup called Ambrosia emerged offering transfusion from young people at $8,000 a session. According to the U.S Food and Drug Administration, there were no clinical benefits of this treatment, and it was shortly shut down. PayPal founder Peter Thiel believes he will live to be 120 years old; a fan of young blood transfusions, he also credits his future success to taking human growth hormones daily and following a strict paleo diet. The science of which diet is best for anti-ageing is constantly changing. The paleo diet cuts out sugar, carbohydrates and highly processed food and is praised by celebs, but is not currently supported by science for having anti-aging benefits. Other diets such as intermittent fasting, keto and veganism are all praised for their anti-aging properties, but again the claims are under-researched. However, there is a growing body of evidence that a whole-food, plant-based diet can aid in the prevention, and in some cases reversal, of chronic diseases (Solway et al., 2020). For example, in Loma Linda, California, one of the world's five original blue zones (areas of the world with the healthiest, longest-living populations), the life expectancy is 10 years longer than the average American, which has been linked to the high number of Adventist vegetarians in the community. The key link between all five blue zones is a mostly whole-food, plant-based diet. Ethical and social implications – consequences of immortal humans The cure to ageing is still a while away but there is already a growing body of evidence of how we can extend our lifespans, but is that a good idea? The first argument against extending human lifespans is the risk of furthering the gaps in inequality. There is already a 30–40-year life expectancy gap between first-world and third-world countries. As highlighted in this article, it is primarily the wealthy benefiting from advancements in anti-ageing. Although, it is the responsibility of politicians and governments to remove the disparities worldwide. Thus, the question arises – should our focus and resources be directed towards addressing the health crises in developing countries instead? The second argument is overpopulation. An interesting study that looked at a 100-year projection of population size if no one aged after 60 showed that total population size only increased by 22% or 9 million to 11 million (Gavrilov & Gavrilova, 2010). They also pointed out that many members of society may choose to reject new anti-ageing technologies due to religious reasons, fear of side effects and/or costs. I would also like to point out that the world’s declining birth rates due to increased fertility issues may also mean overpopulation won’t be a near-future issue. An increasing population size does however mean increased demand for finite resources like water. Increases in water demand could cause an increase in civil and international conflicts over existing water supplies. In Australia, water scarcity is already a persistent issue, given the relatively dry and variable climate and an increased population size will see demand rise above our limits. To conclude, science has not found a cure for mortality, but with the development in age reversal or anti-ageing science, we may see the longevity of life increasing as well as quality of life. There are several ethical and social implications of an “un-ageable” race, but most importantly, developments in the anti-ageing community may allow loved ones to be healthier for longer. References AIHW, Australian Institute of Health and Welfare. (2024). Deaths in Australia. Retrieved from https://www.aihw.gov.au/reports/life-expectancy-deaths/deaths-in-australia Bannister, C. A., Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G.,Mukherjee, J., & Currie, C. J. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab , 16 (11), 1165-1173. https://doi.org/10.1111/dom.12354 Bailey, C. J. (2017). Metformin: historical overview. Diabetologia , 60 (9), 1566-1576. Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005). Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature , 433 (7027), 760-764. https://doi.org/10.1038/nature03260 Gavrilov, L. A., & Gavrilova, N. S. (2010). Demographic consequences of defeating aging. Rejuvenation Res , 13 (2-3), 329-334. https://doi.org/10.1089/rej.2009.0977 doi.org Metformin: historical overview - Diabetologia Metformin (dimethylbiguanide) has become the preferred first-line oral blood glucose-lowering agent to manage type 2 diabetes. Its history is linked to Galega officinalis (also known as goat’s rue), a traditional herbal medicine in Europe, found to be rich in guanidine, which, in 1918, was shown to lower blood glucose. Guanidine derivatives, including metformin, were synthesised and some (not metformin) were used to treat diabetes in the 1920s and 1930s but were discontinued due to toxicity and the increased availability of insulin. Metformin was rediscovered in the search for antimalarial agents in the 1940s and, during clinical tests, proved useful to treat influenza when it sometimes lowered blood glucose. This property was pursued by the French physician Jean Sterne, who first reported the use of metformin to treat diabetes in 1957. However, metformin received limited attention as it was less potent than other glucose-lowering biguanides (phenformin and buformin), which were generally discontinued in the late 1970s due to high risk of lactic acidosis. Metformin’s future was precarious, its reputation tarnished by association with other biguanides despite evident differences. The ability of metformin to counter insulin resistance and address adult-onset hyperglycaemia without weight gain or increased risk of hypoglycaemia gradually gathered credence in Europe, and after intensive scrutiny metformin was introduced into the USA in 1995. Long-term cardiovascular benefits of metformin were identified by the UK Prospective Diabetes Study (UKPDS) in 1998, providing a new rationale to adopt metformin as initial therapy to manage hyperglycaemia in type 2 diabetes. Sixty years after its introduction in diabetes treatment, metformin has become the most prescribed glucose-lowering medicine worldwide with the potential for further therapeutic applications. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., & Miller, R. A. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature , 460 (7253), 392-395. https://doi.org/10.1038/nature08221 Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M. J., Schwab, M., Pollak, M., Zhang, Y., Yu, Y., Becker, K. G., Bohr, V. A., Ingram, D. K., Sinclair, D. A., Wolf, N. S., . . . de Cabo, R. (2013). Metformin improves healthspan and lifespan in mice. Nat Commun , 4 , 2192. https://doi.org/10.1038/ncomms3192 Mannick, J. B., Morris, M., Hockey, H.-U. P., Roma, G., Beibel, M., Kulmatycki, K., Watkins, M., Shavlakadze, T., Zhou, W., Quinn, D., Glass, D. J., & Klickstein, L. B. (2018). TORC1 inhibition enhances immune function and reduces infections in the elderly. Science Translational Medicine , 10 (449), eaaq1564. https://doi.org/doi:10.1126/scitranslmed.aaq1564 Scott, C., & DeFrancesco, L. (2015). Selling Long Life. Nature Biotechnology , 33 , 28-37. Solway, J., McBride, M., Haq, F., Abdul, W., & Miller, R. (2020). Diet and Dermatology: The Role of a Whole-food, doi.org Selling long life - Nature Biotechnology A new generation of commercial entities is beginning to explore opportunities for new types of interventions and services in a graying world. Plant-based Diet in Preventing and Reversing Skin Aging-A Review. J Clin Aesthet Dermatol , 13 (5), 38-43. Poganik, J. R., Zhang, B., Baht, G. S., Tyshkovskiy, A., Deik, A., Kerepesi, C., Yim, S. H., Lu, A. T.,Haghani, A., Gong, T., Hedman, A. M., Andolf, E., Pershagen, G., Almqvist, C., Clish, C. B., Horvath, S., White, J. P., & Gladyshev, V. N. (2023). Biological age is increased by stress and restored upon recovery. Cell Metab , 35 (5), 807-820.e805. https://doi.org/10.1016/j.cmet.2023.03.015 Previous article Next article apex back to